MC937A1 - Procédé de préparations d'inhibiteurs de xanthine-oxydase - Google Patents

Procédé de préparations d'inhibiteurs de xanthine-oxydase

Info

Publication number
MC937A1
MC937A1 MC1005A MC1005A MC937A1 MC 937 A1 MC937 A1 MC 937A1 MC 1005 A MC1005 A MC 1005A MC 1005 A MC1005 A MC 1005A MC 937 A1 MC937 A1 MC 937A1
Authority
MC
Monaco
Prior art keywords
solution
amino
product
sodium
water
Prior art date
Application number
MC1005A
Other languages
English (en)
French (fr)
Original Assignee
Int Chem & Nuclear Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Chem & Nuclear Corp filed Critical Int Chem & Nuclear Corp
Publication of MC937A1 publication Critical patent/MC937A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC1005A 1971-08-16 1972-08-02 Procédé de préparations d'inhibiteurs de xanthine-oxydase MC937A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17219571A 1971-08-16 1971-08-16
US261103A US3920652A (en) 1971-08-16 1972-06-08 Aromatic substituted pyrazola {8 1,5a{9 {0 pyrimidine compounds useful as xanthine oxidase inhibitors

Publications (1)

Publication Number Publication Date
MC937A1 true MC937A1 (fr) 1973-08-10

Family

ID=26867834

Family Applications (1)

Application Number Title Priority Date Filing Date
MC1005A MC937A1 (fr) 1971-08-16 1972-08-02 Procédé de préparations d'inhibiteurs de xanthine-oxydase

Country Status (19)

Country Link
US (1) US3920652A (enExample)
JP (1) JPS4834899A (enExample)
AR (1) AR193536A1 (enExample)
AT (1) AT330780B (enExample)
BE (1) BE786611A (enExample)
BG (1) BG19806A3 (enExample)
DD (1) DD99581A5 (enExample)
DE (1) DE2236987A1 (enExample)
ES (1) ES405663A1 (enExample)
FR (1) FR2150771B1 (enExample)
GB (1) GB1359563A (enExample)
HU (1) HU167466B (enExample)
IE (1) IE36629B1 (enExample)
IL (1) IL39988A0 (enExample)
LU (1) LU65892A1 (enExample)
MC (1) MC937A1 (enExample)
NL (1) NL7211011A (enExample)
RO (1) RO63871A (enExample)
SU (1) SU522800A3 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093617A (en) * 1974-11-12 1978-06-06 Icn Pharmaceuticals, Inc. 3,5,7-Trisubstituted pyrazolo[1,5-a]pyrimidines
US4048184A (en) * 1976-11-15 1977-09-13 E. R. Squibb & Sons, Inc. 6-Phenyl-2H-pyrazolo[3,4-b]pyridines
US4281000A (en) * 1979-07-09 1981-07-28 American Cyanamid Company Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents
AU557300B2 (en) * 1982-03-16 1986-12-18 Farmitalia Carlo Erba S.P.A. Substituted 1h-pyrazolo(1,5-alpha)pyrimidines and processes for their preparation
ZA831407B (en) * 1982-03-25 1983-11-30 Erba Farmitalia Substituted ethenyl derivatives of 1h-pyrazolo(1,5-a)pyrimidine and process for their preparation
WO1992006096A1 (fr) * 1990-10-09 1992-04-16 Otsuka Pharmaceutical Co., Ltd. Derive de pyrimidine, production de ce derive et inhibiteur d'androgenes
AU667575B2 (en) * 1992-10-20 1996-03-28 Otsuka Pharmaceutical Co., Ltd. Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor
AU707530B2 (en) * 1995-09-28 1999-07-15 Otsuka Pharmaceutical Factory, Inc. Analgesic composition
US6664261B2 (en) * 1996-02-07 2003-12-16 Neurocrine Biosciences, Inc. Pyrazolopyrimidines as CRF receptor antagonists
HU228962B1 (en) * 1996-07-24 2013-07-29 Bristol Myers Squibb Pharma Co Azolo triazines, pharmaceutical compositions containing them and use of the compounds
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6235741B1 (en) * 1997-05-30 2001-05-22 Merck & Co., Inc. Angiogenesis inhibitors
EP1044002A4 (en) 1997-11-07 2003-05-02 Univ Johns Hopkins METHODS FOR THE TREATMENT OF HEART CONTRACTILITY
US6380203B1 (en) * 1998-01-14 2002-04-30 Merck & Co., Inc. Angiogenesis inhibitors
AU4331500A (en) 1999-04-06 2000-10-23 Du Pont Pharmaceuticals Company Pyrazolotriazines as crf antagonists
WO2000059908A2 (en) 1999-04-06 2000-10-12 Du Pont Pharmaceuticals Company Pyrazolopyrimidines as crf antagonists
US6630476B2 (en) 2000-07-07 2003-10-07 Bristol-Myers Squibb Pharma Company Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
WO2015186117A1 (en) 2014-06-06 2015-12-10 Siemens Medical Solutions Usa, Inc. Gamma camera dead time determination in real time using long lived radioisotopes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3048587A (en) * 1960-10-17 1962-08-07 Ortho Pharma Corp 2-alkylamino-4-aminopyrimidine
US3296268A (en) * 1965-10-19 1967-01-03 Searle & Co 3-cyanoethyl-2-oxo-5-phenyl [1, 5-a] pyrimidines

Also Published As

Publication number Publication date
BG19806A3 (bg) 1975-10-10
US3920652A (en) 1975-11-18
SU522800A3 (ru) 1976-07-25
GB1359563A (en) 1974-07-10
RO63871A (fr) 1979-01-15
BE786611A (fr) 1973-01-22
DD99581A5 (enExample) 1973-08-12
AT330780B (de) 1976-07-26
LU65892A1 (enExample) 1973-01-15
FR2150771B1 (enExample) 1976-05-21
HU167466B (enExample) 1975-10-28
NL7211011A (enExample) 1973-02-20
FR2150771A1 (enExample) 1973-04-13
AR193536A1 (es) 1973-04-30
DE2236987A1 (de) 1973-03-01
JPS4834899A (enExample) 1973-05-22
IE36629L (en) 1973-02-16
ES405663A1 (es) 1976-01-16
IL39988A0 (en) 1972-09-28
IE36629B1 (en) 1977-01-19
ATA677372A (de) 1975-10-15

Similar Documents

Publication Publication Date Title
MC937A1 (fr) Procédé de préparations d'inhibiteurs de xanthine-oxydase
US3907799A (en) Xanthine oxidase inhibitors
SU1072803A3 (ru) Способ получени производных фталазин-4-илуксусной кислоты или их солей
LU83886A1 (fr) Nouveaux derives de la furo-(3,4-c)-pyridine leur preparation et leur emploi therapeutique
EP0022762B1 (fr) Nouveaux dérivés d'indolizine, leur procédé de préparation ainsi que leurs applications en thérapeutique
LU85248A1 (fr) Derives de thiazolidine,procede pour leur preparation et compositions pharmaceutiques les contenant
FR2543956A1 (fr) Derives de la furo-(3,4-c)-pyridine ainsi que leur preparation
FR2647676A1 (fr) Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
JPH04210683A (ja) チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US4021556A (en) Xanthine oxidase inhibitors
EP0162776A2 (fr) Dérivés hétérocycliques, leurs procédés de préparation,médicaments les contenant, utiles notamment comme inhibiteurs de l'aldose réductase
JP3483160B2 (ja) ピリドピリミジンジオン類、その製造方法およびそれを含有する薬剤
CH631179A5 (fr) Tetrahydro-4,5,6,7 thieno (2,3-c) et (3,2-c) pyridines et leur procede de preparation.
MC1255A1 (fr) L'acide 7-methoxy-5-oxo-5h-thiazolo(2,3-b)quinazoline-2-carboxylique et ses sels,leur preparation et leurs utilisations therapeutiques
WO1993017023A1 (fr) Derives de pyrazolopyrimidines antagonistes des recepteurs a l'angiotensine ii
EP0172097B1 (fr) Imidazo(1,2-a)quinolines, leur préparation et leur application en thérapeutique
FR2742153A1 (fr) Utilisation de derives tricycliques du 1,4-dihydro-1,4- dioxo-1h-naphtalene, nouveaux composes obtenus et leur application en therapeutique
FR2669633A1 (fr) Nouveaux derives de la benzoselenazolinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2742151A1 (fr) Utilisation de derives de bicycles mono ou dicetoniques, nouveaux composes obtenus et leur application en therapeutique
US4219668A (en) 4-Hydroxy,4-biphenylbutyric acid
FR2742155A1 (fr) Utilisation de derives heteroaromatiques et tricycliques du 1,4-dihydro-1,4-dioxonaphtalene, nouveaux composes obtenus et leur application en therapeutique
MC1186A1 (fr) Derives de quinazoline
JPH0613515B2 (ja) ピラゾロ〔１，５−ａ〕ピリジン誘導体及びそれを含有する治療剤
EP0098204A1 (fr) Compositions thérapeutiques à base d'hydrazones N-substituées et nouvelles hydrazones N-substituées
FR2564463A1 (fr) Nouveaux derives heterocycliques, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase